Global Molecular Diagnostics Cancer Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Molecular Diagnostics Cancer will have significant change from previous year. According to our (LP Information) latest study, the global Molecular Diagnostics Cancer market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Molecular Diagnostics Cancer market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Molecular Diagnostics Cancer market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Molecular Diagnostics Cancer market, reaching US$ million by the year 2028. As for the Europe Molecular Diagnostics Cancer landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Molecular Diagnostics Cancer players cover Roche, Danaher, Siemens, and Abbott Laboratories, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Diagnostics Cancer market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
As the global economy mends, the 2021 growth of Molecular Diagnostics Cancer will have significant change from previous year. According to our (LP Information) latest study, the global Molecular Diagnostics Cancer market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Molecular Diagnostics Cancer market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Molecular Diagnostics Cancer market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Molecular Diagnostics Cancer market, reaching US$ million by the year 2028. As for the Europe Molecular Diagnostics Cancer landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Molecular Diagnostics Cancer players cover Roche, Danaher, Siemens, and Abbott Laboratories, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Diagnostics Cancer market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- Pharmacogenomic Diagnosis
- Liquid Biopsy
- Other
- Respiratory Cancer
- Cancer of Digestive System
- Cancer of Urinary System
- Cancer of Circulatory System
- Motor System Cancer
- Reproductive System Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Danaher
- Siemens
- Abbott Laboratories
- ICON Plc
- AstraZeneca
- MDxHealth
- Invitae
- PlexBio
- Thermo Fisher Scientific
- Guardant Health
- Biocartis
- Bio-Techne
- Merck
- Foundation Medicine
- 10X Genomics
- Biodesix
- CytoTrack
- GenomOncology
- Luminex
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Molecular Diagnostics Cancer Market Size 2017-2028
2.1.2 Molecular Diagnostics Cancer Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Molecular Diagnostics Cancer Segment by Type
2.2.1 Pharmacogenomic Diagnosis
2.2.2 Liquid Biopsy
2.2.3 Other
2.3 Molecular Diagnostics Cancer Market Size by Type
2.3.1 Molecular Diagnostics Cancer Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2022)
2.4 Molecular Diagnostics Cancer Segment by Application
2.4.1 Respiratory Cancer
2.4.2 Cancer of Digestive System
2.4.3 Cancer of Urinary System
2.4.4 Cancer of Circulatory System
2.4.5 Motor System Cancer
2.4.6 Reproductive System Cancer
2.4.7 Other
2.5 Molecular Diagnostics Cancer Market Size by Application
2.5.1 Molecular Diagnostics Cancer Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2022)
3 MOLECULAR DIAGNOSTICS CANCER MARKET SIZE BY PLAYER
3.1 Molecular Diagnostics Cancer Market Size Market Share by Players
3.1.1 Global Molecular Diagnostics Cancer Revenue by Players (2020-2022)
3.1.2 Global Molecular Diagnostics Cancer Revenue Market Share by Players (2020-2022)
3.2 Global Molecular Diagnostics Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MOLECULAR DIAGNOSTICS CANCER BY REGIONS
4.1 Molecular Diagnostics Cancer Market Size by Regions (2017-2022)
4.2 Americas Molecular Diagnostics Cancer Market Size Growth (2017-2022)
4.3 APAC Molecular Diagnostics Cancer Market Size Growth (2017-2022)
4.4 Europe Molecular Diagnostics Cancer Market Size Growth (2017-2022)
4.5 Middle East & Africa Molecular Diagnostics Cancer Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Molecular Diagnostics Cancer Market Size by Country (2017-2022)
5.2 Americas Molecular Diagnostics Cancer Market Size by Type (2017-2022)
5.3 Americas Molecular Diagnostics Cancer Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Diagnostics Cancer Market Size by Region (2017-2022)
6.2 APAC Molecular Diagnostics Cancer Market Size by Type (2017-2022)
6.3 APAC Molecular Diagnostics Cancer Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Molecular Diagnostics Cancer by Country (2017-2022)
7.2 Europe Molecular Diagnostics Cancer Market Size by Type (2017-2022)
7.3 Europe Molecular Diagnostics Cancer Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Molecular Diagnostics Cancer by Region (2017-2022)
8.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2017-2022)
8.3 Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MOLECULAR DIAGNOSTICS CANCER MARKET FORECAST
10.1 Global Molecular Diagnostics Cancer Forecast by Regions (2023-2028)
10.1.1 Global Molecular Diagnostics Cancer Forecast by Regions (2023-2028)
10.1.2 Americas Molecular Diagnostics Cancer Forecast
10.1.3 APAC Molecular Diagnostics Cancer Forecast
10.1.4 Europe Molecular Diagnostics Cancer Forecast
10.1.5 Middle East & Africa Molecular Diagnostics Cancer Forecast
10.2 Americas Molecular Diagnostics Cancer Forecast by Country (2023-2028)
10.2.1 United States Molecular Diagnostics Cancer Market Forecast
10.2.2 Canada Molecular Diagnostics Cancer Market Forecast
10.2.3 Mexico Molecular Diagnostics Cancer Market Forecast
10.2.4 Brazil Molecular Diagnostics Cancer Market Forecast
10.3 APAC Molecular Diagnostics Cancer Forecast by Region (2023-2028)
10.3.1 China Molecular Diagnostics Cancer Market Forecast
10.3.2 Japan Molecular Diagnostics Cancer Market Forecast
10.3.3 Korea Molecular Diagnostics Cancer Market Forecast
10.3.4 Southeast Asia Molecular Diagnostics Cancer Market Forecast
10.3.5 India Molecular Diagnostics Cancer Market Forecast
10.3.6 Australia Molecular Diagnostics Cancer Market Forecast
10.4 Europe Molecular Diagnostics Cancer Forecast by Country (2023-2028)
10.4.1 Germany Molecular Diagnostics Cancer Market Forecast
10.4.2 France Molecular Diagnostics Cancer Market Forecast
10.4.3 UK Molecular Diagnostics Cancer Market Forecast
10.4.4 Italy Molecular Diagnostics Cancer Market Forecast
10.4.5 Russia Molecular Diagnostics Cancer Market Forecast
10.5 Middle East & Africa Molecular Diagnostics Cancer Forecast by Region (2023-2028)
10.5.1 Egypt Molecular Diagnostics Cancer Market Forecast
10.5.2 South Africa Molecular Diagnostics Cancer Market Forecast
10.5.3 Israel Molecular Diagnostics Cancer Market Forecast
10.5.4 Turkey Molecular Diagnostics Cancer Market Forecast
10.5.5 GCC Countries Molecular Diagnostics Cancer Market Forecast
10.6 Global Molecular Diagnostics Cancer Forecast by Type (2023-2028)
10.7 Global Molecular Diagnostics Cancer Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Molecular Diagnostics Cancer Product Offered
11.1.3 Roche Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Danaher
11.2.1 Danaher Company Information
11.2.2 Danaher Molecular Diagnostics Cancer Product Offered
11.2.3 Danaher Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Danaher Main Business Overview
11.2.5 Danaher Latest Developments
11.3 Siemens
11.3.1 Siemens Company Information
11.3.2 Siemens Molecular Diagnostics Cancer Product Offered
11.3.3 Siemens Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Siemens Main Business Overview
11.3.5 Siemens Latest Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Information
11.4.2 Abbott Laboratories Molecular Diagnostics Cancer Product Offered
11.4.3 Abbott Laboratories Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Abbott Laboratories Main Business Overview
11.4.5 Abbott Laboratories Latest Developments
11.5 ICON Plc
11.5.1 ICON Plc Company Information
11.5.2 ICON Plc Molecular Diagnostics Cancer Product Offered
11.5.3 ICON Plc Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 ICON Plc Main Business Overview
11.5.5 ICON Plc Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Molecular Diagnostics Cancer Product Offered
11.6.3 AstraZeneca Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 MDxHealth
11.7.1 MDxHealth Company Information
11.7.2 MDxHealth Molecular Diagnostics Cancer Product Offered
11.7.3 MDxHealth Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 MDxHealth Main Business Overview
11.7.5 MDxHealth Latest Developments
11.8 Invitae
11.8.1 Invitae Company Information
11.8.2 Invitae Molecular Diagnostics Cancer Product Offered
11.8.3 Invitae Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Invitae Main Business Overview
11.8.5 Invitae Latest Developments
11.9 PlexBio
11.9.1 PlexBio Company Information
11.9.2 PlexBio Molecular Diagnostics Cancer Product Offered
11.9.3 PlexBio Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 PlexBio Main Business Overview
11.9.5 PlexBio Latest Developments
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Information
11.10.2 Thermo Fisher Scientific Molecular Diagnostics Cancer Product Offered
11.10.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Thermo Fisher Scientific Main Business Overview
11.10.5 Thermo Fisher Scientific Latest Developments
11.11 Guardant Health
11.11.1 Guardant Health Company Information
11.11.2 Guardant Health Molecular Diagnostics Cancer Product Offered
11.11.3 Guardant Health Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Guardant Health Main Business Overview
11.11.5 Guardant Health Latest Developments
11.12 Biocartis
11.12.1 Biocartis Company Information
11.12.2 Biocartis Molecular Diagnostics Cancer Product Offered
11.12.3 Biocartis Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Biocartis Main Business Overview
11.12.5 Biocartis Latest Developments
11.13 Bio-Techne
11.13.1 Bio-Techne Company Information
11.13.2 Bio-Techne Molecular Diagnostics Cancer Product Offered
11.13.3 Bio-Techne Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Bio-Techne Main Business Overview
11.13.5 Bio-Techne Latest Developments
11.14 Merck
11.14.1 Merck Company Information
11.14.2 Merck Molecular Diagnostics Cancer Product Offered
11.14.3 Merck Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Merck Main Business Overview
11.14.5 Merck Latest Developments
11.15 Foundation Medicine
11.15.1 Foundation Medicine Company Information
11.15.2 Foundation Medicine Molecular Diagnostics Cancer Product Offered
11.15.3 Foundation Medicine Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Foundation Medicine Main Business Overview
11.15.5 Foundation Medicine Latest Developments
11.16 10X Genomics
11.16.1 10X Genomics Company Information
11.16.2 10X Genomics Molecular Diagnostics Cancer Product Offered
11.16.3 10X Genomics Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 10X Genomics Main Business Overview
11.16.5 10X Genomics Latest Developments
11.17 Biodesix
11.17.1 Biodesix Company Information
11.17.2 Biodesix Molecular Diagnostics Cancer Product Offered
11.17.3 Biodesix Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Biodesix Main Business Overview
11.17.5 Biodesix Latest Developments
11.18 CytoTrack
11.18.1 CytoTrack Company Information
11.18.2 CytoTrack Molecular Diagnostics Cancer Product Offered
11.18.3 CytoTrack Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 CytoTrack Main Business Overview
11.18.5 CytoTrack Latest Developments
11.19 GenomOncology
11.19.1 GenomOncology Company Information
11.19.2 GenomOncology Molecular Diagnostics Cancer Product Offered
11.19.3 GenomOncology Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 GenomOncology Main Business Overview
11.19.5 GenomOncology Latest Developments
11.20 Luminex
11.20.1 Luminex Company Information
11.20.2 Luminex Molecular Diagnostics Cancer Product Offered
11.20.3 Luminex Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Luminex Main Business Overview
11.20.5 Luminex Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Molecular Diagnostics Cancer Market Size 2017-2028
2.1.2 Molecular Diagnostics Cancer Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Molecular Diagnostics Cancer Segment by Type
2.2.1 Pharmacogenomic Diagnosis
2.2.2 Liquid Biopsy
2.2.3 Other
2.3 Molecular Diagnostics Cancer Market Size by Type
2.3.1 Molecular Diagnostics Cancer Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2022)
2.4 Molecular Diagnostics Cancer Segment by Application
2.4.1 Respiratory Cancer
2.4.2 Cancer of Digestive System
2.4.3 Cancer of Urinary System
2.4.4 Cancer of Circulatory System
2.4.5 Motor System Cancer
2.4.6 Reproductive System Cancer
2.4.7 Other
2.5 Molecular Diagnostics Cancer Market Size by Application
2.5.1 Molecular Diagnostics Cancer Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2022)
3 MOLECULAR DIAGNOSTICS CANCER MARKET SIZE BY PLAYER
3.1 Molecular Diagnostics Cancer Market Size Market Share by Players
3.1.1 Global Molecular Diagnostics Cancer Revenue by Players (2020-2022)
3.1.2 Global Molecular Diagnostics Cancer Revenue Market Share by Players (2020-2022)
3.2 Global Molecular Diagnostics Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MOLECULAR DIAGNOSTICS CANCER BY REGIONS
4.1 Molecular Diagnostics Cancer Market Size by Regions (2017-2022)
4.2 Americas Molecular Diagnostics Cancer Market Size Growth (2017-2022)
4.3 APAC Molecular Diagnostics Cancer Market Size Growth (2017-2022)
4.4 Europe Molecular Diagnostics Cancer Market Size Growth (2017-2022)
4.5 Middle East & Africa Molecular Diagnostics Cancer Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Molecular Diagnostics Cancer Market Size by Country (2017-2022)
5.2 Americas Molecular Diagnostics Cancer Market Size by Type (2017-2022)
5.3 Americas Molecular Diagnostics Cancer Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Diagnostics Cancer Market Size by Region (2017-2022)
6.2 APAC Molecular Diagnostics Cancer Market Size by Type (2017-2022)
6.3 APAC Molecular Diagnostics Cancer Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Molecular Diagnostics Cancer by Country (2017-2022)
7.2 Europe Molecular Diagnostics Cancer Market Size by Type (2017-2022)
7.3 Europe Molecular Diagnostics Cancer Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Molecular Diagnostics Cancer by Region (2017-2022)
8.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2017-2022)
8.3 Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MOLECULAR DIAGNOSTICS CANCER MARKET FORECAST
10.1 Global Molecular Diagnostics Cancer Forecast by Regions (2023-2028)
10.1.1 Global Molecular Diagnostics Cancer Forecast by Regions (2023-2028)
10.1.2 Americas Molecular Diagnostics Cancer Forecast
10.1.3 APAC Molecular Diagnostics Cancer Forecast
10.1.4 Europe Molecular Diagnostics Cancer Forecast
10.1.5 Middle East & Africa Molecular Diagnostics Cancer Forecast
10.2 Americas Molecular Diagnostics Cancer Forecast by Country (2023-2028)
10.2.1 United States Molecular Diagnostics Cancer Market Forecast
10.2.2 Canada Molecular Diagnostics Cancer Market Forecast
10.2.3 Mexico Molecular Diagnostics Cancer Market Forecast
10.2.4 Brazil Molecular Diagnostics Cancer Market Forecast
10.3 APAC Molecular Diagnostics Cancer Forecast by Region (2023-2028)
10.3.1 China Molecular Diagnostics Cancer Market Forecast
10.3.2 Japan Molecular Diagnostics Cancer Market Forecast
10.3.3 Korea Molecular Diagnostics Cancer Market Forecast
10.3.4 Southeast Asia Molecular Diagnostics Cancer Market Forecast
10.3.5 India Molecular Diagnostics Cancer Market Forecast
10.3.6 Australia Molecular Diagnostics Cancer Market Forecast
10.4 Europe Molecular Diagnostics Cancer Forecast by Country (2023-2028)
10.4.1 Germany Molecular Diagnostics Cancer Market Forecast
10.4.2 France Molecular Diagnostics Cancer Market Forecast
10.4.3 UK Molecular Diagnostics Cancer Market Forecast
10.4.4 Italy Molecular Diagnostics Cancer Market Forecast
10.4.5 Russia Molecular Diagnostics Cancer Market Forecast
10.5 Middle East & Africa Molecular Diagnostics Cancer Forecast by Region (2023-2028)
10.5.1 Egypt Molecular Diagnostics Cancer Market Forecast
10.5.2 South Africa Molecular Diagnostics Cancer Market Forecast
10.5.3 Israel Molecular Diagnostics Cancer Market Forecast
10.5.4 Turkey Molecular Diagnostics Cancer Market Forecast
10.5.5 GCC Countries Molecular Diagnostics Cancer Market Forecast
10.6 Global Molecular Diagnostics Cancer Forecast by Type (2023-2028)
10.7 Global Molecular Diagnostics Cancer Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Molecular Diagnostics Cancer Product Offered
11.1.3 Roche Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Danaher
11.2.1 Danaher Company Information
11.2.2 Danaher Molecular Diagnostics Cancer Product Offered
11.2.3 Danaher Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Danaher Main Business Overview
11.2.5 Danaher Latest Developments
11.3 Siemens
11.3.1 Siemens Company Information
11.3.2 Siemens Molecular Diagnostics Cancer Product Offered
11.3.3 Siemens Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Siemens Main Business Overview
11.3.5 Siemens Latest Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Information
11.4.2 Abbott Laboratories Molecular Diagnostics Cancer Product Offered
11.4.3 Abbott Laboratories Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Abbott Laboratories Main Business Overview
11.4.5 Abbott Laboratories Latest Developments
11.5 ICON Plc
11.5.1 ICON Plc Company Information
11.5.2 ICON Plc Molecular Diagnostics Cancer Product Offered
11.5.3 ICON Plc Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 ICON Plc Main Business Overview
11.5.5 ICON Plc Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Molecular Diagnostics Cancer Product Offered
11.6.3 AstraZeneca Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 MDxHealth
11.7.1 MDxHealth Company Information
11.7.2 MDxHealth Molecular Diagnostics Cancer Product Offered
11.7.3 MDxHealth Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 MDxHealth Main Business Overview
11.7.5 MDxHealth Latest Developments
11.8 Invitae
11.8.1 Invitae Company Information
11.8.2 Invitae Molecular Diagnostics Cancer Product Offered
11.8.3 Invitae Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Invitae Main Business Overview
11.8.5 Invitae Latest Developments
11.9 PlexBio
11.9.1 PlexBio Company Information
11.9.2 PlexBio Molecular Diagnostics Cancer Product Offered
11.9.3 PlexBio Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 PlexBio Main Business Overview
11.9.5 PlexBio Latest Developments
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Information
11.10.2 Thermo Fisher Scientific Molecular Diagnostics Cancer Product Offered
11.10.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Thermo Fisher Scientific Main Business Overview
11.10.5 Thermo Fisher Scientific Latest Developments
11.11 Guardant Health
11.11.1 Guardant Health Company Information
11.11.2 Guardant Health Molecular Diagnostics Cancer Product Offered
11.11.3 Guardant Health Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Guardant Health Main Business Overview
11.11.5 Guardant Health Latest Developments
11.12 Biocartis
11.12.1 Biocartis Company Information
11.12.2 Biocartis Molecular Diagnostics Cancer Product Offered
11.12.3 Biocartis Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Biocartis Main Business Overview
11.12.5 Biocartis Latest Developments
11.13 Bio-Techne
11.13.1 Bio-Techne Company Information
11.13.2 Bio-Techne Molecular Diagnostics Cancer Product Offered
11.13.3 Bio-Techne Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Bio-Techne Main Business Overview
11.13.5 Bio-Techne Latest Developments
11.14 Merck
11.14.1 Merck Company Information
11.14.2 Merck Molecular Diagnostics Cancer Product Offered
11.14.3 Merck Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Merck Main Business Overview
11.14.5 Merck Latest Developments
11.15 Foundation Medicine
11.15.1 Foundation Medicine Company Information
11.15.2 Foundation Medicine Molecular Diagnostics Cancer Product Offered
11.15.3 Foundation Medicine Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Foundation Medicine Main Business Overview
11.15.5 Foundation Medicine Latest Developments
11.16 10X Genomics
11.16.1 10X Genomics Company Information
11.16.2 10X Genomics Molecular Diagnostics Cancer Product Offered
11.16.3 10X Genomics Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 10X Genomics Main Business Overview
11.16.5 10X Genomics Latest Developments
11.17 Biodesix
11.17.1 Biodesix Company Information
11.17.2 Biodesix Molecular Diagnostics Cancer Product Offered
11.17.3 Biodesix Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Biodesix Main Business Overview
11.17.5 Biodesix Latest Developments
11.18 CytoTrack
11.18.1 CytoTrack Company Information
11.18.2 CytoTrack Molecular Diagnostics Cancer Product Offered
11.18.3 CytoTrack Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 CytoTrack Main Business Overview
11.18.5 CytoTrack Latest Developments
11.19 GenomOncology
11.19.1 GenomOncology Company Information
11.19.2 GenomOncology Molecular Diagnostics Cancer Product Offered
11.19.3 GenomOncology Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 GenomOncology Main Business Overview
11.19.5 GenomOncology Latest Developments
11.20 Luminex
11.20.1 Luminex Company Information
11.20.2 Luminex Molecular Diagnostics Cancer Product Offered
11.20.3 Luminex Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Luminex Main Business Overview
11.20.5 Luminex Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Molecular Diagnostics Cancer Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Pharmacogenomic Diagnosis
Table 3. Major Players of Liquid Biopsy
Table 4. Major Players of Other
Table 5. Molecular Diagnostics Cancer Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Molecular Diagnostics Cancer Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2022)
Table 8. Molecular Diagnostics Cancer Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Molecular Diagnostics Cancer Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2022)
Table 11. Global Molecular Diagnostics Cancer Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Molecular Diagnostics Cancer Revenue Market Share by Player (2020-2022)
Table 13. Molecular Diagnostics Cancer Key Players Head office and Products Offered
Table 14. Molecular Diagnostics Cancer Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Molecular Diagnostics Cancer Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Molecular Diagnostics Cancer Market Size Market Share by Regions (2017-2022)
Table 19. Americas Molecular Diagnostics Cancer Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Molecular Diagnostics Cancer Market Size Market Share by Country (2017-2022)
Table 21. Americas Molecular Diagnostics Cancer Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2022)
Table 23. Americas Molecular Diagnostics Cancer Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2022)
Table 25. APAC Molecular Diagnostics Cancer Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Molecular Diagnostics Cancer Market Size Market Share by Region (2017-2022)
Table 27. APAC Molecular Diagnostics Cancer Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2022)
Table 29. APAC Molecular Diagnostics Cancer Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2022)
Table 31. Europe Molecular Diagnostics Cancer Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Molecular Diagnostics Cancer Market Size Market Share by Country (2017-2022)
Table 33. Europe Molecular Diagnostics Cancer Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2022)
Table 35. Europe Molecular Diagnostics Cancer Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Molecular Diagnostics Cancer Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Molecular Diagnostics Cancer Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Molecular Diagnostics Cancer
Table 44. Key Market Challenges & Risks of Molecular Diagnostics Cancer
Table 45. Key Industry Trends of Molecular Diagnostics Cancer
Table 46. Global Molecular Diagnostics Cancer Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Molecular Diagnostics Cancer Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Molecular Diagnostics Cancer Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Molecular Diagnostics Cancer Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Molecular Diagnostics Cancer Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Molecular Diagnostics Cancer Market Size Market Share Forecast by Application (2023-2028)
Table 52. Roche Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 53. Roche Molecular Diagnostics Cancer Product Offered
Table 54. Roche Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Roche Main Business
Table 56. Roche Latest Developments
Table 57. Danaher Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 58. Danaher Molecular Diagnostics Cancer Product Offered
Table 59. Danaher Main Business
Table 60. Danaher Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Danaher Latest Developments
Table 62. Siemens Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 63. Siemens Molecular Diagnostics Cancer Product Offered
Table 64. Siemens Main Business
Table 65. Siemens Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Siemens Latest Developments
Table 67. Abbott Laboratories Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 68. Abbott Laboratories Molecular Diagnostics Cancer Product Offered
Table 69. Abbott Laboratories Main Business
Table 70. Abbott Laboratories Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Abbott Laboratories Latest Developments
Table 72. ICON Plc Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 73. ICON Plc Molecular Diagnostics Cancer Product Offered
Table 74. ICON Plc Main Business
Table 75. ICON Plc Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. ICON Plc Latest Developments
Table 77. AstraZeneca Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 78. AstraZeneca Molecular Diagnostics Cancer Product Offered
Table 79. AstraZeneca Main Business
Table 80. AstraZeneca Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. AstraZeneca Latest Developments
Table 82. MDxHealth Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 83. MDxHealth Molecular Diagnostics Cancer Product Offered
Table 84. MDxHealth Main Business
Table 85. MDxHealth Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. MDxHealth Latest Developments
Table 87. Invitae Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 88. Invitae Molecular Diagnostics Cancer Product Offered
Table 89. Invitae Main Business
Table 90. Invitae Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Invitae Latest Developments
Table 92. PlexBio Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 93. PlexBio Molecular Diagnostics Cancer Product Offered
Table 94. PlexBio Main Business
Table 95. PlexBio Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. PlexBio Latest Developments
Table 97. Thermo Fisher Scientific Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 98. Thermo Fisher Scientific Molecular Diagnostics Cancer Product Offered
Table 99. Thermo Fisher Scientific Main Business
Table 100. Thermo Fisher Scientific Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Thermo Fisher Scientific Latest Developments
Table 102. Guardant Health Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 103. Guardant Health Molecular Diagnostics Cancer Product Offered
Table 104. Guardant Health Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Guardant Health Main Business
Table 106. Guardant Health Latest Developments
Table 107. Biocartis Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 108. Biocartis Molecular Diagnostics Cancer Product Offered
Table 109. Biocartis Main Business
Table 110. Biocartis Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Biocartis Latest Developments
Table 112. Bio-Techne Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 113. Bio-Techne Molecular Diagnostics Cancer Product Offered
Table 114. Bio-Techne Main Business
Table 115. Bio-Techne Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. Bio-Techne Latest Developments
Table 117. Merck Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 118. Merck Molecular Diagnostics Cancer Product Offered
Table 119. Merck Main Business
Table 120. Merck Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. Merck Latest Developments
Table 122. Foundation Medicine Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 123. Foundation Medicine Molecular Diagnostics Cancer Product Offered
Table 124. Foundation Medicine Main Business
Table 125. Foundation Medicine Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 126. Foundation Medicine Latest Developments
Table 127. 10X Genomics Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 128. 10X Genomics Molecular Diagnostics Cancer Product Offered
Table 129. 10X Genomics Main Business
Table 130. 10X Genomics Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 131. 10X Genomics Latest Developments
Table 132. Biodesix Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 133. Biodesix Molecular Diagnostics Cancer Product Offered
Table 134. Biodesix Main Business
Table 135. Biodesix Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 136. Biodesix Latest Developments
Table 137. CytoTrack Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 138. CytoTrack Molecular Diagnostics Cancer Product Offered
Table 139. CytoTrack Main Business
Table 140. CytoTrack Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 141. CytoTrack Latest Developments
Table 142. GenomOncology Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 143. GenomOncology Molecular Diagnostics Cancer Product Offered
Table 144. GenomOncology Main Business
Table 145. GenomOncology Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 146. GenomOncology Latest Developments
Table 147. Luminex Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 148. Luminex Molecular Diagnostics Cancer Product Offered
Table 149. Luminex Main Business
Table 150. Luminex Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 151. Luminex Latest Developments
Table 1. Molecular Diagnostics Cancer Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Pharmacogenomic Diagnosis
Table 3. Major Players of Liquid Biopsy
Table 4. Major Players of Other
Table 5. Molecular Diagnostics Cancer Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Molecular Diagnostics Cancer Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2022)
Table 8. Molecular Diagnostics Cancer Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Molecular Diagnostics Cancer Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2022)
Table 11. Global Molecular Diagnostics Cancer Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Molecular Diagnostics Cancer Revenue Market Share by Player (2020-2022)
Table 13. Molecular Diagnostics Cancer Key Players Head office and Products Offered
Table 14. Molecular Diagnostics Cancer Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Molecular Diagnostics Cancer Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Molecular Diagnostics Cancer Market Size Market Share by Regions (2017-2022)
Table 19. Americas Molecular Diagnostics Cancer Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Molecular Diagnostics Cancer Market Size Market Share by Country (2017-2022)
Table 21. Americas Molecular Diagnostics Cancer Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2022)
Table 23. Americas Molecular Diagnostics Cancer Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2022)
Table 25. APAC Molecular Diagnostics Cancer Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Molecular Diagnostics Cancer Market Size Market Share by Region (2017-2022)
Table 27. APAC Molecular Diagnostics Cancer Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2022)
Table 29. APAC Molecular Diagnostics Cancer Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2022)
Table 31. Europe Molecular Diagnostics Cancer Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Molecular Diagnostics Cancer Market Size Market Share by Country (2017-2022)
Table 33. Europe Molecular Diagnostics Cancer Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2022)
Table 35. Europe Molecular Diagnostics Cancer Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Molecular Diagnostics Cancer Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Molecular Diagnostics Cancer Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Molecular Diagnostics Cancer
Table 44. Key Market Challenges & Risks of Molecular Diagnostics Cancer
Table 45. Key Industry Trends of Molecular Diagnostics Cancer
Table 46. Global Molecular Diagnostics Cancer Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Molecular Diagnostics Cancer Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Molecular Diagnostics Cancer Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Molecular Diagnostics Cancer Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Molecular Diagnostics Cancer Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Molecular Diagnostics Cancer Market Size Market Share Forecast by Application (2023-2028)
Table 52. Roche Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 53. Roche Molecular Diagnostics Cancer Product Offered
Table 54. Roche Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Roche Main Business
Table 56. Roche Latest Developments
Table 57. Danaher Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 58. Danaher Molecular Diagnostics Cancer Product Offered
Table 59. Danaher Main Business
Table 60. Danaher Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Danaher Latest Developments
Table 62. Siemens Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 63. Siemens Molecular Diagnostics Cancer Product Offered
Table 64. Siemens Main Business
Table 65. Siemens Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Siemens Latest Developments
Table 67. Abbott Laboratories Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 68. Abbott Laboratories Molecular Diagnostics Cancer Product Offered
Table 69. Abbott Laboratories Main Business
Table 70. Abbott Laboratories Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Abbott Laboratories Latest Developments
Table 72. ICON Plc Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 73. ICON Plc Molecular Diagnostics Cancer Product Offered
Table 74. ICON Plc Main Business
Table 75. ICON Plc Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. ICON Plc Latest Developments
Table 77. AstraZeneca Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 78. AstraZeneca Molecular Diagnostics Cancer Product Offered
Table 79. AstraZeneca Main Business
Table 80. AstraZeneca Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. AstraZeneca Latest Developments
Table 82. MDxHealth Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 83. MDxHealth Molecular Diagnostics Cancer Product Offered
Table 84. MDxHealth Main Business
Table 85. MDxHealth Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. MDxHealth Latest Developments
Table 87. Invitae Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 88. Invitae Molecular Diagnostics Cancer Product Offered
Table 89. Invitae Main Business
Table 90. Invitae Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Invitae Latest Developments
Table 92. PlexBio Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 93. PlexBio Molecular Diagnostics Cancer Product Offered
Table 94. PlexBio Main Business
Table 95. PlexBio Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. PlexBio Latest Developments
Table 97. Thermo Fisher Scientific Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 98. Thermo Fisher Scientific Molecular Diagnostics Cancer Product Offered
Table 99. Thermo Fisher Scientific Main Business
Table 100. Thermo Fisher Scientific Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Thermo Fisher Scientific Latest Developments
Table 102. Guardant Health Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 103. Guardant Health Molecular Diagnostics Cancer Product Offered
Table 104. Guardant Health Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Guardant Health Main Business
Table 106. Guardant Health Latest Developments
Table 107. Biocartis Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 108. Biocartis Molecular Diagnostics Cancer Product Offered
Table 109. Biocartis Main Business
Table 110. Biocartis Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Biocartis Latest Developments
Table 112. Bio-Techne Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 113. Bio-Techne Molecular Diagnostics Cancer Product Offered
Table 114. Bio-Techne Main Business
Table 115. Bio-Techne Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. Bio-Techne Latest Developments
Table 117. Merck Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 118. Merck Molecular Diagnostics Cancer Product Offered
Table 119. Merck Main Business
Table 120. Merck Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. Merck Latest Developments
Table 122. Foundation Medicine Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 123. Foundation Medicine Molecular Diagnostics Cancer Product Offered
Table 124. Foundation Medicine Main Business
Table 125. Foundation Medicine Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 126. Foundation Medicine Latest Developments
Table 127. 10X Genomics Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 128. 10X Genomics Molecular Diagnostics Cancer Product Offered
Table 129. 10X Genomics Main Business
Table 130. 10X Genomics Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 131. 10X Genomics Latest Developments
Table 132. Biodesix Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 133. Biodesix Molecular Diagnostics Cancer Product Offered
Table 134. Biodesix Main Business
Table 135. Biodesix Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 136. Biodesix Latest Developments
Table 137. CytoTrack Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 138. CytoTrack Molecular Diagnostics Cancer Product Offered
Table 139. CytoTrack Main Business
Table 140. CytoTrack Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 141. CytoTrack Latest Developments
Table 142. GenomOncology Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 143. GenomOncology Molecular Diagnostics Cancer Product Offered
Table 144. GenomOncology Main Business
Table 145. GenomOncology Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 146. GenomOncology Latest Developments
Table 147. Luminex Details, Company Type, Molecular Diagnostics Cancer Area Served and Its Competitors
Table 148. Luminex Molecular Diagnostics Cancer Product Offered
Table 149. Luminex Main Business
Table 150. Luminex Molecular Diagnostics Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 151. Luminex Latest Developments
LIST OF FIGURES
Figure 1. Molecular Diagnostics Cancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Molecular Diagnostics Cancer Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Molecular Diagnostics Cancer Market Size Market Share by Type in 2021
Figure 7. Molecular Diagnostics Cancer in Respiratory Cancer
Figure 8. Global Molecular Diagnostics Cancer Market: Respiratory Cancer (2017-2022) & ($ Millions)
Figure 9. Molecular Diagnostics Cancer in Cancer of Digestive System
Figure 10. Global Molecular Diagnostics Cancer Market: Cancer of Digestive System (2017-2022) & ($ Millions)
Figure 11. Molecular Diagnostics Cancer in Cancer of Urinary System
Figure 12. Global Molecular Diagnostics Cancer Market: Cancer of Urinary System (2017-2022) & ($ Millions)
Figure 13. Molecular Diagnostics Cancer in Cancer of Circulatory System
Figure 14. Global Molecular Diagnostics Cancer Market: Cancer of Circulatory System (2017-2022) & ($ Millions)
Figure 15. Molecular Diagnostics Cancer in Motor System Cancer
Figure 16. Global Molecular Diagnostics Cancer Market: Motor System Cancer (2017-2022) & ($ Millions)
Figure 17. Molecular Diagnostics Cancer in Reproductive System Cancer
Figure 18. Global Molecular Diagnostics Cancer Market: Reproductive System Cancer (2017-2022) & ($ Millions)
Figure 19. Molecular Diagnostics Cancer in Other
Figure 20. Global Molecular Diagnostics Cancer Market: Other (2017-2022) & ($ Millions)
Figure 21. Global Molecular Diagnostics Cancer Market Size Market Share by Application in 2021
Figure 22. Global Molecular Diagnostics Cancer Revenue Market Share by Player in 2021
Figure 23. Global Molecular Diagnostics Cancer Market Size Market Share by Regions (2017-2022)
Figure 24. Americas Molecular Diagnostics Cancer Market Size 2017-2022 ($ Millions)
Figure 25. APAC Molecular Diagnostics Cancer Market Size 2017-2022 ($ Millions)
Figure 26. Europe Molecular Diagnostics Cancer Market Size 2017-2022 ($ Millions)
Figure 27. Middle East & Africa Molecular Diagnostics Cancer Market Size 2017-2022 ($ Millions)
Figure 28. Americas Molecular Diagnostics Cancer Value Market Share by Country in 2021
Figure 29. Americas Molecular Diagnostics Cancer Consumption Market Share by Type in 2021
Figure 30. Americas Molecular Diagnostics Cancer Market Size Market Share by Application in 2021
Figure 31. United States Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 32. Canada Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 33. Mexico Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 34. Brazil Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 35. APAC Molecular Diagnostics Cancer Market Size Market Share by Region in 2021
Figure 36. APAC Molecular Diagnostics Cancer Market Size Market Share by Application in 2021
Figure 37. China Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 38. Japan Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 39. Korea Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 40. Southeast Asia Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 41. India Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 42. Australia Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 43. Europe Molecular Diagnostics Cancer Market Size Market Share by Country in 2021
Figure 44. Europe Molecular Diagnostics Cancer Market Size Market Share by Type in 2021
Figure 45. Europe Molecular Diagnostics Cancer Market Size Market Share by Application in 2021
Figure 46. Germany Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 47. France Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 48. UK Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 49. Italy Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 50. Russia Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 51. Middle East & Africa Molecular Diagnostics Cancer Market Size Market Share by Region in 2021
Figure 52. Middle East & Africa Molecular Diagnostics Cancer Market Size Market Share by Type in 2021
Figure 53. Middle East & Africa Molecular Diagnostics Cancer Market Size Market Share by Application in 2021
Figure 54. Egypt Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 55. South Africa Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 56. Israel Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 57. Turkey Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 58. GCC Country Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 59. Americas Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 60. APAC Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 61. Europe Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 62. Middle East & Africa Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 63. United States Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 64. Canada Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 65. Mexico Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 66. Brazil Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 67. China Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 68. Japan Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 69. Korea Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 70. Southeast Asia Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 71. India Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 72. Australia Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 73. Germany Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 74. France Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 75. UK Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 76. Italy Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 77. Russia Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 78. Spain Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 79. Egypt Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 80. South Africa Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 81. Israel Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 82. Turkey Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 83. GCC Countries Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 1. Molecular Diagnostics Cancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Molecular Diagnostics Cancer Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Molecular Diagnostics Cancer Market Size Market Share by Type in 2021
Figure 7. Molecular Diagnostics Cancer in Respiratory Cancer
Figure 8. Global Molecular Diagnostics Cancer Market: Respiratory Cancer (2017-2022) & ($ Millions)
Figure 9. Molecular Diagnostics Cancer in Cancer of Digestive System
Figure 10. Global Molecular Diagnostics Cancer Market: Cancer of Digestive System (2017-2022) & ($ Millions)
Figure 11. Molecular Diagnostics Cancer in Cancer of Urinary System
Figure 12. Global Molecular Diagnostics Cancer Market: Cancer of Urinary System (2017-2022) & ($ Millions)
Figure 13. Molecular Diagnostics Cancer in Cancer of Circulatory System
Figure 14. Global Molecular Diagnostics Cancer Market: Cancer of Circulatory System (2017-2022) & ($ Millions)
Figure 15. Molecular Diagnostics Cancer in Motor System Cancer
Figure 16. Global Molecular Diagnostics Cancer Market: Motor System Cancer (2017-2022) & ($ Millions)
Figure 17. Molecular Diagnostics Cancer in Reproductive System Cancer
Figure 18. Global Molecular Diagnostics Cancer Market: Reproductive System Cancer (2017-2022) & ($ Millions)
Figure 19. Molecular Diagnostics Cancer in Other
Figure 20. Global Molecular Diagnostics Cancer Market: Other (2017-2022) & ($ Millions)
Figure 21. Global Molecular Diagnostics Cancer Market Size Market Share by Application in 2021
Figure 22. Global Molecular Diagnostics Cancer Revenue Market Share by Player in 2021
Figure 23. Global Molecular Diagnostics Cancer Market Size Market Share by Regions (2017-2022)
Figure 24. Americas Molecular Diagnostics Cancer Market Size 2017-2022 ($ Millions)
Figure 25. APAC Molecular Diagnostics Cancer Market Size 2017-2022 ($ Millions)
Figure 26. Europe Molecular Diagnostics Cancer Market Size 2017-2022 ($ Millions)
Figure 27. Middle East & Africa Molecular Diagnostics Cancer Market Size 2017-2022 ($ Millions)
Figure 28. Americas Molecular Diagnostics Cancer Value Market Share by Country in 2021
Figure 29. Americas Molecular Diagnostics Cancer Consumption Market Share by Type in 2021
Figure 30. Americas Molecular Diagnostics Cancer Market Size Market Share by Application in 2021
Figure 31. United States Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 32. Canada Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 33. Mexico Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 34. Brazil Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 35. APAC Molecular Diagnostics Cancer Market Size Market Share by Region in 2021
Figure 36. APAC Molecular Diagnostics Cancer Market Size Market Share by Application in 2021
Figure 37. China Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 38. Japan Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 39. Korea Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 40. Southeast Asia Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 41. India Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 42. Australia Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 43. Europe Molecular Diagnostics Cancer Market Size Market Share by Country in 2021
Figure 44. Europe Molecular Diagnostics Cancer Market Size Market Share by Type in 2021
Figure 45. Europe Molecular Diagnostics Cancer Market Size Market Share by Application in 2021
Figure 46. Germany Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 47. France Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 48. UK Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 49. Italy Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 50. Russia Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 51. Middle East & Africa Molecular Diagnostics Cancer Market Size Market Share by Region in 2021
Figure 52. Middle East & Africa Molecular Diagnostics Cancer Market Size Market Share by Type in 2021
Figure 53. Middle East & Africa Molecular Diagnostics Cancer Market Size Market Share by Application in 2021
Figure 54. Egypt Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 55. South Africa Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 56. Israel Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 57. Turkey Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 58. GCC Country Molecular Diagnostics Cancer Market Size Growth 2017-2022 ($ Millions)
Figure 59. Americas Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 60. APAC Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 61. Europe Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 62. Middle East & Africa Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 63. United States Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 64. Canada Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 65. Mexico Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 66. Brazil Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 67. China Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 68. Japan Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 69. Korea Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 70. Southeast Asia Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 71. India Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 72. Australia Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 73. Germany Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 74. France Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 75. UK Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 76. Italy Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 77. Russia Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 78. Spain Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 79. Egypt Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 80. South Africa Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 81. Israel Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 82. Turkey Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
Figure 83. GCC Countries Molecular Diagnostics Cancer Market Size 2023-2028 ($ Millions)
